Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive Value of T2-weighted Perfusion and T1-weighted Permeability MRI Parameters in Determining IDH Mutational Status and Grade of Gliomas.

Turkish neurosurgery - 1 Jan 2024

Yuzkan Sabahattin, Karagulle Mehmet, Ozdemir Merve Sam, Mutlu Samet, Kocak Burak

Abstract excerpt

AIM: To assess the performance metrics of perfusion and permeability magnetic resonance imaging (MRI) parameters with optimal cut-offs in differentiating isocitrate dehydrogenase (IDH) genotype and tumor grade in patients with grade 2-4 gliomas. MATERIAL AND METHODS: This retrospective study included 36 patients surgically diagnosed with grade 2-4 glioma (six grade 2, seven grade 3, and 23 grade 4) with known IDH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Neoplasm Grading

Share to Predictive Value of Tests

Share to Young Adult

Source

Identifiers

PMID: 39474970
DOI: 10.5137/1019-5149.JTN.46251-24.3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive Value of T2-weighted Perfusion and T1-weighted Permeability MRI Parameters in Determining IDH Mutational Status and Grade of Gliomas.PMID 39474970Read ↗

The role of DSC MR perfusion in predicting IDH mutation and 1p19q codeletion status in gliomas: meta-analysis and technical considerations.Semantic proximity Read ↗

Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.Semantic proximity Read ↗

Distributed parameter model of dynamic contrast-enhanced MRI in the identification of IDH mutation, 1p19q codeletion, and tumor cell proliferation in glioma patientsSemantic proximity Read ↗

Vascular differences between glioblastoma <i>IDH-wildtype</i> and astrocytoma <i>IDH</i>-mutant grade 4 at imaging and transcriptomic levelSemantic proximity Read ↗

Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels.Semantic proximity Read ↗

Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.Semantic proximity Read ↗

Unveiling intratumoral heterogeneity and isocitrate dehydrogenase status in gliomas: a simultaneous fluorine-18 fluorodeoxyglucose PET/MRI study based on 2021 WHO classification.Semantic proximity Read ↗

Characterisation of isocitrate dehydrogenase gene mutant WHO grade 2 and 3 gliomas: MRI predictors of 1p/19q co-deletion and tumour grade.Semantic proximity Read ↗

WHO CNS5 2021 includes specific mutations in gliomas that can be identified with MRI quantitative biomarkers.Semantic proximity Read ↗

Comprehensive multicentre retrospective analysis for predicting isocitrate dehydrogenase-mutant lower-grade gliomas.Semantic proximity Read ↗

MRI-based deep learning techniques for the prediction of isocitrate dehydrogenase and 1p/19q status in grade 2-4 adult gliomas.Semantic proximity Read ↗

Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.